| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | €8,6844 | -0,10% | €155,89M | €6,146 | |
BRR ProCap Financial, Inc. Common Stock | €1,6333 | +0,00% | €155,82M | €461,00 | |
HUMA Humacyte, Inc. Common Stock | €0,56216 | +0,25% | €155,36M | €32,67K | |
HTLM HomesToLife Ltd Ordinary Shares | €1,6860 | +4,92% | €155,14M | €0,8781 | |
| €46,9740 | +0,05% | €154,95M | €25,31K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | €14,6994 | +0,00% | €154,81M | €15,17K | |
PAAC Proem Acquisition Corp I Ordinary Shares | €8,7415 | -0,05% | €154,69M | €93,95 | |
BNR Burning Rock Biotech Limited American Depositary Shares | €8,1224 | +3,35% | €154,65M | €4,390 | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,8724 | -0,45% | €154,47M | €3,512 | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | €8,9478 | +0,00% | €154,11M | €6,146 | |
| €3,2841 | -0,80% | €154,00M | €104,59K | |
ECBK ECB Bancorp, Inc. Common Stock | €17,8254 | +0,35% | €153,81M | €6,72K | |
TNXP Tonix Pharmaceuticals Holding Corp. | €9,3430 | +0,19% | €153,69M | €338,94 | |
| €7,9117 | -0,11% | €153,57M | €198,35K | |
DHF BNY Mellon High Yield Strategies Fund | €2,0921 | +0,95% | €153,28M | €359,99K | |
